Transcriptional and post-transcriptional regulation of PenA β-lactamase in acquired Burkholderia pseudomallei β-lactam resistance

Scientific Reports
Sunisa ChirakulHerbert P Schweizer

Abstract

Therapy of Burkholderia pseudomallei acute infections is largely limited to a few β-lactam antibiotics such as ceftazidime or meropenem. Although relatively rare, resistance emergence during therapy leads to treatment failures with high mortality rates. In the absence of acquired external resistance determinants in B. pseudomallei emergence of β-lactam resistance is invariably caused by mutational modification of genomically encoded factors. These include the deletion of the ceftazidime target penicillin-binding protein 3 or amino acid changes in the Class A PenA β-lactamase that expand its substrate spectrum, as well as penA gene duplication and amplification or its overexpression via transcriptional up-regulation. Evidence is presented that penA is co-transcribed with the upstream nlpD1 gene, that the transcriptional terminator for nlpD1 serves as a penA attenuator and that generation of a new promoter immediately upstream of the terminator/attenuator by a conserved G to A transition leads to anti-termination and thus constitutive PenA expression and extended β-lactam resistance. Further evidence obtained with the extensively β-lactam resistant clinical isolate Bp1651 shows that in addition to PenA overexpression and structur...Continue Reading

References

Feb 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·T Grundström, B Jaurin
Feb 12, 1998·Proceedings of the National Academy of Sciences of the United States of America·S M Uptain, M J Chamberlin
Mar 26, 2003·The Journal of Antimicrobial Chemotherapy·Steven D MahlenNancy D Hanson
Apr 5, 2007·Nature Protocols·Kyoung-Hee Choi, Herbert P Schweizer
Dec 25, 2007·Applied and Environmental Microbiology·Kyoung-Hee ChoiHerbert P Schweizer
Oct 10, 2008·Bioinformatics·Geoffrey L WinsorFiona S L Brinkman
Jan 16, 2009·Transactions of the Royal Society of Tropical Medicine and Hygiene·Ayush KumarHerbert P Schweizer
Aug 25, 2009·Applied and Environmental Microbiology·Carolina M LópezHerbert P Schweizer
Mar 20, 2010·The EMBO Journal·Tsuyoshi UeharaThomas G Bernhardt
Jul 13, 2011·Frontiers in Microbiology·Drew A RhollHerbert P Schweizer
Oct 5, 2011·Proceedings of the National Academy of Sciences of the United States of America·Narisara ChantratitaSharon J Peacock
May 23, 2012·PloS One·Hillary S HaydenMichael A Jacobs
Sep 15, 2012·Infection and Drug Resistance·Derek S SarovichTalima Pearson
Jun 5, 2013·Frontiers in Microbiology·Ximin Zeng, Jun Lin
Nov 7, 2013·MBio·Larry A GallagherColin Manoil
Mar 13, 2014·International Journal of Antimicrobial Agents·David Dance
May 1, 2015·Frontiers in Microbiology·Nicole L PodneckyHerbert P Schweizer
Dec 30, 2015·Antimicrobial Agents and Chemotherapy·Linnell B RandallHerbert P Schweizer
Dec 30, 2015·Journal of Bacteriology·Kieran B PechterCaroline S Harwood
Feb 3, 2016·Proceedings of the National Academy of Sciences of the United States of America·Lu LiXiaohui Zhou
Feb 16, 2016·Nature Microbiology·Direk LimmathurotsakulSimon I Hay
Aug 31, 2016·Nature Microbiology·Direk LimmathurotsakulSimon I Hay
Sep 14, 2016·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Katherine A Rhodes, Herbert P Schweizer
Apr 12, 2017·Antimicrobial Agents and Chemotherapy·Julia V BugryshevaLinda M Weigel
Jun 7, 2017·Proceedings of the National Academy of Sciences of the United States of America·Nitin KumarEdward W Yu
Dec 2, 2017·ACS Synthetic Biology·Johanna RoßmanithFranz Narberhaus
Feb 2, 2018·Nature Reviews. Disease Primers·W Joost WiersingaDirek Limmathurotsakul
Feb 3, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Derek S SarovichErin P Price

❮ Previous
Next ❯

Datasets Mentioned

BETA
CP012041.1
CP012042.1

Methods Mentioned

BETA
PCR

Software Mentioned

BLAST
MUSCLE

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.